ID: ALA4216422

Max Phase: Preclinical

Molecular Formula: C26H36N4O2

Molecular Weight: 436.60

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@@H]1CN(C)[C@H]2Cc3c([nH]c4ccccc34)/C(=N/N=C\C(C)(C)C)C[C@H]1[C@H]2C(=O)OC

Standard InChI:  InChI=1S/C26H36N4O2/c1-7-16-14-30(5)22-13-19-17-10-8-9-11-20(17)28-24(19)21(29-27-15-26(2,3)4)12-18(16)23(22)25(31)32-6/h8-11,15-16,18,22-23,28H,7,12-14H2,1-6H3/b27-15-,29-21+/t16-,18-,22+,23-/m1/s1

Standard InChI Key:  KTNHPEAXZCBPDP-NMQOHJNXSA-N

Associated Targets(Human)

Multidrug resistance-associated protein 1 2587 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

ATP-binding cassette sub-family G member 2 4927 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BHK-21 725 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NIH3T3 5395 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 436.60Molecular Weight (Monoisotopic): 436.2838AlogP: 4.68#Rotatable Bonds: 3
Polar Surface Area: 70.05Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.57CX Basic pKa: 8.46CX LogP: 4.14CX LogD: 3.05
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.43Np Likeness Score: 0.79

References

1. Paterna A, Khonkarn R, Mulhovo S, Moreno A, Madeira Girio P, Baubichon-Cortay H, Falson P, Ferreira MU..  (2018)  Monoterpene indole alkaloid azine derivatives as MDR reversal agents.,  26  (2): [PMID:29233614] [10.1016/j.bmc.2017.11.052]

Source